Facile Procedure for the Synthesis
of N-Aryl-N-hydroxy
Carbamates

Achim Porzelle; Michael D. Woodrow; Nicholas C. O. Tomkinson

doi:10.1055/s-0028-1087943

LETTER

Facile Procedure for the Synthesis of N-Aryl-N-hydroxy Carbamates

Achim Porzelle^a, Michael D. Woodrow^b, Nicholas C. O. Tomkinson*^a
^a School of Chemistry, Main Building, Cardiff University, Park Place, Cardiff, CF10 3AT, UK
e-Mail: porzellea@cardiff.ac.uk; e-Mail: tomkinsonnc@cardiff.ac.uk;
^b ImmunoInflammation Centre of Excellence for Drug Discovery, GlaxoSmithKline Medicines Research Centre, Stevenage, Hertfordshire, SG1 2NY, UK

Abstract

Alle Artikel dieser Rubrik

Abstract

An efficient one-pot procedure for the zinc-mediated reduction of nitroarenes in the presence of chloroformates leading to the corresponding N,O-bisprotected hydroxylamine is described. Reactions proceed smoothly under ambient conditions in THF-water mixtures in good to excellent yield (34-81%). Solvolysis of the bisprotected hydroxylamines with sodium methoxide at room temperature provides access to synthetically versatile N-aryl-N-hydroxy carbamates in excellent yields (89-97%).

Key words

hydroxylamine - carbamate - zinc-mediated reduction

Volltext

Referenzen

References and Notes

1 Schmidt A. Science of Synthesis Vol. 31b: Ramsden CA. Thieme; Stuttgart: 2007. p.1739

2 For the preparation of indoles, see: Blechert S. Tetrahedron Lett. 1984, 25: 1547

3 For the preparation of isoxazolidines, see: Imran M. Khan SA. Siddiqui N. Ind. J. Pharm. Sci. 2004, 66: 377

4 For the preparation of oxadiazolidinones, see: Gopalsamy A. Kincaid SL. Ellingboe JW. Groeling TM. Antrilli TM. Krishnamurthy G. Aulaugh A. Friedrichs GS. Crandall DL. Bioorg. Med. Chem. Lett. 2004, 14: 3477

5 For the preparation of aziridines, see: Murugan E. Siva A. Synthesis 2005, 2022

For the preparation of nitrones, see:

6a Evans DA. Song H.-J. Fandrick KR. Org. Lett. 2006, 8: 3351

6b Chatterjee A. Bhattacharya PK. J. Org. Chem. 2006, 71: 345

6c Young IS. Williams JL. Kerr MA. Org. Lett. 2005, 7: 953

For applications in [3,3]-sigmatropic rearrangements, see:

7a Porzelle A. Woodrow MD. Tomkinson NCO. Eur. J. Org. Chem. 2008, 5135

7b Lobo AM. Prabhakar S. Pure Appl. Chem. 1997, 69: 547

8 Srivastava RS. Khan MA. Nicholas KM. J. Am. Chem. Soc. 2005, 127: 7278

9 For the preparation of β-amino acids, see: Fuller AA. Chen B. Minter AR. Mapp AK. J. Am. Chem. Soc. 2005, 127: 5376

10 For the preparation of β-amino alcohols, see: Aschwanden P. Kværnø L. Geisser RW. Kleinbeck F. Carreira EM. Org. Lett. 2005, 7: 5741 ; and references cited therein

11 Johansson W. Parkinson GN. Denny WA. Neidel S. J. Med. Chem. 2003, 46: 4009

12a Beshara CS. Hall A. Jenkins RL. Jones KL. Jones TC. Killeen NM. Taylor PH. Thomas SP. Tomkinson NCO. Org. Lett. 2005, 7: 5729

12b Beshara CS. Hall A. Jenkins RL. Jones TC. Parry RT. Thomas SP. Tomkinson NCO. Chem. Commun. 2005, 1478

12c Hall A. Jones KL. Jones TC. Killeen NM. Porzig R. Taylor PH. Yau SC. Tomkinson NCO. Synlett 2006, 3435

12d Hall A. Huguet EP. Jones KL. Jones TC. Killeen NM. Yau SC. Tomkinson NCO. Synlett 2007, 293

12e Jones TC. Tomkinson NCO. Org. Synth. 2007, 84: 233

12f Knowles DA. Mathews CJ. Tomkinson NCO. Synlett 2008, 2769

13 Jones KL. Porzelle A. Hall A. Woodrow MD. Tomkinson NCO. Org. Lett. 2008, 10: 797

14 Porzelle A. Woodrow MD. Tomkinson NCO. Org. Lett. 2009, 11: 233

15 Kamm O. Org. Synth., Coll. Vol. I 1941, 445

16a Ayyanger NR. Brahme KC. Kalkote UR. Srinivasan KV. Synthesis 1984, 938

16b Entwistle ID. Gilkerson T. Johnstone RAW. Telford RP. Tetrahedron 1978, 34: 213

16c Rondestvedt CS. Johnson TA. Synthesis 1977, 850

For example:

17a Ren P.-D. Pan X.-W. Jin Q.-H. Yao Z.-P. Synth. Commun. 1997, 27: 3497

17b Ren P.-D. Dong T. Wu S. Synth. Commun. 1997, 27: 1547

17c Bartra M. Romea P. Urpí F. Vilarrasa J. Tetrahedron 1990, 46: 587

17d Yanada K. Yamaguchi H. Meguri H. Uchida S. J. Chem. Soc., Chem. Commun. 1986, 1655

17e Uchida S. Yanada K. Yamaguchi H. Meguri H. Chem. Lett. 1986, 1069

18 Shi QX. Lu RW. Jin K. Zhang ZX. Zhao DF. Chem. Lett. 2006, 35: 226

19 Kin BH. Cheong JW. Han R. Jun YM. Baik W. Lee BM. Synth. Commun. 2001, 31: 3577

20 Kin BH. Jun YM. Suh SW. Baik W. Lee BM. J. Chem. Res., Synop. 1998, 46

21

Spectroscopic Data for New CompoundsBenzyl N-Phenyl-N-(benzoxycarbonyloxy) Carbamate
^¹H NMR (400 MHz, CDCl₃): δ = 7.47-7.45 (m, 2 H), 7.40-7.26 (m, 13 H), 5.26 (s, 2 H), 5.22 (s, 2 H). ^¹³C NMR (62.5 MHz, CDCl₃): δ = 154.2, 153.4, 139.4, 135.4, 134.1, 129.1, 129.0, 128.8, 128.7, 128.6, 128.5, 128.4, 128.0, 127.7, 124.0, 71.6, 68.6. HRMS: m/z calcd for [M + H]⁺ C₂₂H₁₉NO₅Na: 400.1161; found: 400.1167.
Benzyl N-4-Tolyl-N-(benzoxycarbonyloxy) Carbamate
^¹H NMR (400 MHz, CDCl₃): δ = 7.40-7.29 (m, 12 H), 7.18 (d, 2 H, J = 8.0 Hz), 5.27 (s, 2 H), 5.24 (s, 2 H), 2.25 (s, 3 H). ^¹³C NMR (62.5 MHz, CDCl₃): δ = 154.7, 153.0, 140.7, 136.0, 135.5, 134.5, 129.7, 129.0, 128.8, 128.7, 128.6, 128.4, 122.0, 70.9, 67.2, 20.9. HRMS: m/z calcd for [M + H]⁺ C₂₃H₂₂NO₅: 392.1498; found: 392.1497.
Benzyl N-4-Cyano-N-(benzoxycarbonyloxy) Carbamate
^¹H NMR (400 MHz, CDCl₃): δ = 7.65-7.58 (m, 4 H), 7.39-7.31 (m, 10 H), 5.28 (s, 2 H), 5.27 (s, 2 H). ^¹³C NMR (62.5 MHz, CDCl₃): δ = 153.6, 151.9, 143.0, 134.7, 133.7, 133.0, 129.3, 128.8, 128.7, 128.6, 128.2, 120.1, 118.4, 109.1, 72.3, 69.2. HRMS: m/z calcd for [M + NH₄]⁺ C₂₃H₂₂N₃O₅: 420.1559; found: 420.1570.
Benzyl N-3-Trifluoromethylphenyl-N-(benzoxycarbonyl-oxy) Carbamate
^¹H NMR (400 MHz, CDCl₃): δ = 7.74 (br s, 1 H), 7.66-7.64 (m, 1 H), 7.50-7.49 (m, 2 H), 7.39-7.30 (m, 10 H), 5.27 (s, 2 H), 5.26 (s, 2 H). ^¹³C NMR (62.5 MHz, CDCl₃): δ = 153.9, 152.7, 140.0, 135.0, 133.9, 131.8 (q, CF₃, J = 42 Hz), 129.6, 129.1, 128.8, 128.7, 128.6, 128.5, 128.1, 125.6, 123.6, 123.6, 119.5, 72.0, 69.0. HRMS: m/z calcd for [M + NH₄]⁺ C₂₃H₂₂F₃N₂O₅: 463.1481; found: 463.1472.
Methyl N-2-Tolyl-N-(methoxycarbonyloxy) Carbamate
^¹H NMR (400 MHz, CDCl₃): δ = 7.44 (d, 1 H, J = 7.8 Hz), 7.29-7.24 (m, 3 H), 3.88 (s, 3 H), 3.82 (s, 3 H), 2.37 (s, 3 H). ^¹³C NMR (62.5 MHz, CDCl₃): δ = 154.8, 154.8, 137.8, 137.4, 131.1, 129.5, 128.5, 126.7, 56.2, 54.0, 17.16. HRMS: m/z calcd for [M + H]⁺ C₁₁H₁₄NO₅: 240.0872; found: 240.0867.
Methyl N-3-Tolyl-N-(methoxycarbonyloxy) Carbamate
^¹H NMR (500 MHz, CDCl₃): δ = 7.31-7.28 (m, 3 H), 7.15 (d, 1 H, J = 7.0 Hz), 3.94 (s, 3 H), 3.87 (s, 3 H), 2.39 (s, 3 H). ^¹³C NMR (125 MHz, CDCl₃): δ = 154.7, 154.1, 139.2, 139.1, 128.9, 128.8, 125.1, 121.5, 56.4, 54.0, 21.5. HRMS: m/z calcd for [M + H]⁺ C₁₁H₁₄NO₅: 240.0872; found: 240.0863.
Methyl N-4-Tolyl-N-(methoxycarbonyloxy) Carbamate
^¹H NMR (400 MHz, CDCl₃): δ = 7.34 (d, 2 H, J = 8.1 Hz), 7.19 (d, 2 H, J = 8.1 Hz), 3.90 (s, 3 H), 3.83 (s, 3 H), 2.36 (s, 3 H). ^¹³C NMR (62.5 MHz, CDCl₃): δ = 154.8, 154.3, 138.4, 136.8, 129.7, 125.1, 56.3, 53.9, 21.1. HRMS: m/z calcd for [M + H]⁺ C₁₁H₁₁NO₅: 240.0866; found: 240.0868.
Methyl N-3-Trifluoromethylphenyl-N-(methoxycar-bonyloxy) Carbamate
^¹H NMR (400 MHz, CDCl₃): δ = 7.75 (s, 1 H), 7.68-7.66 (m, 1 H), 7.54-7.52 (m, 2 H), 3.96 (s, 3 H), 3.89 (s, 3 H). ^¹³C NMR (62.5 MHz, CDCl₃): δ = 154.4, 153.4, 139.9, 131.4 (q, CF₃, J = 32 Hz), 129.5, 125.9, 123.8, 121.4, 119.6, 56.7, 54.2. HRMS: m/z calcd for [M + H]⁺ C₁₁H₁₁NO₅F₃: 294.0589; found: 294.0589.
Methyl N-4-Iodophenyl-N-(methoxycarbonyloxy) Carbamate
^¹H NMR (400 MHz, CDCl₃): δ = 7.63 (d, 2 H, J = 4.8 Hz), 7.14 (d, 2 H, J = 4.8 Hz), 3.84 (s, 3 H), 3.77 (s, 3 H). ^¹³C NMR (62.5 MHz, CDCl₃): δ = 154.5, 153.5, 139.1, 138.1, 125.2, 92.3, 56.6, 54.2. HRMS: m/z calcd for [M + H]⁺ C₁₀H₁₁NO₅ ^¹²7I: 351.9682; found: 351.9675.
Methyl N-4-Cyanophenyl-N-(methoxycarbonyloxy) Carbamate
^¹H NMR (400 MHz, CDCl₃): δ = 7.63 (d, 2 H, J = 8.1 Hz), 7.58 (d, 2 H, J = 7.0 Hz), 3.94 (s, 3 H), 3.88 (s, 3 H). ^¹³C NMR (62.5 MHz, CDCl₃): δ = 154.1, 152.5, 143.0, 133.0, 120.3, 118.3, 109.2, 57.0, 54.4. HRMS: m/z calcd for [M + NH₄]⁺ C₁₁H₁₄N₃O₅: 268.0928; found: 268.0931.

22

Phenyl N-Phenyl-N-hydroxy Carbamate
^¹H NMR (400 MHz, CDCl₃): δ = 7.85 (br s, 1 H), 7.54 (d, 2 H, J = 7.8 Hz), 7.40-7.35 (m, 4 H), 7.26-7.22 (m, 2 H), 7.14 (d, 2 H, J = 7.8 Hz). ^¹³C NMR (62.5 MHz, CDCl₃): δ = 153.7, 150.7, 140.2, 129.5, 128.8, 126.5, 126.0, 122.5, 121.5. HRMS: m/z calcd for [M + H]⁺ C₁₃H₁₂NO₃: 230.0812; found: 230.0812.
Phenyl N-4-Tolyl-N-hydroxy Carbamate
^¹H NMR (400 MHz, CDCl₃): δ = 7.88 (br s, 1 H), 7.41-7.33 (m, 4 H), 7.25-7.21 (m, 1 H), 7.19-7.11 (m, 4 H), 2.36 (s, 3 H). ^¹³C NMR (62.5 MHz, CDCl₃): δ = 153.8, 150.8, 137.7, 136.7, 129.5, 129.4, 125.9, 123.0, 121.5, 21.0. HRMS: m/z calcd for [M + NH₄]⁺ C₁₄H₁₇N₂O₃: 261.1239; found: 261.1230.
Benzyl N-4-Tolyl-N-hydroxy Carbamate
^¹H NMR (400 MHz, CDCl₃): δ = 7.37-7.30 (m, 7 H), 7.15 (d, 2 H, J = 8.2 Hz), 5.21 (s, 2 H), 2.23 (s, 3 H). ^¹³C NMR (62.5 MHz, CDCl₃): δ = 155.6, 140.8, 138.4, 135.8, 129.2, 128.6, 128.1, 127.1, 122.7, 68.3, 21.0. HRMS: m/z calcd for [M + H]⁺ C₁₅H₁₆NO₃: 258.1125; found: 258.1126. Benzyl N-4-Cyano-N-hydroxy Carbamate
^¹H NMR (400 MHz, CDCl₃): δ = 7.70 (d, 2 H, J = 9.0 Hz), 7.58 (d, 2 H, J = 9.0 Hz), 7.43-7.33 (m, 5 H), 5.30 (s, 2 H). ^¹³C NMR (62.5 MHz, CDCl₃): δ = 154.2, 144.7, 134.9, 132.7, 128.98, 128.4, 119.4, 118.8, 107.0 69.1. HRMS: m/z calcd for [M + NH₄]⁺ C₁₅H₁₆N₃O₃: 286.1192; found: 286.1194. Benzyl N-3-Trifluoromethylphenyl-N-hydroxy Carbamate
^¹H NMR (400 MHz, CDCl₃): δ = 7.68 (br s, 1 H), 7.56-7.55 (m, 1 H), 7.31-7.29 (m, 2 H), 7.21-7.13 (m, 5 H), 5.10 (s, 2 H). ^¹³C NMR (62.5 MHz, CDCl₃): δ = 155.0, 141.4, 135.0, 131.0 (q, J = 32 Hz, CF₃), 129.1, 128.7, 128.7, 128.2, 127.8, 127.1, 124.2, 118.1, 69.0. HRMS: m/z calcd for [M + NH₄]⁺ C₁₅H₁₆FN₂O₃: 329.1108; found: 329.1110. Methyl N-2-Tolyl-N-hydroxy Carbamate
^¹H NMR (400 MHz, CDCl₃): δ = 9.0 (br s, 1 H), 7.36-7.33 (m, 1 H), 7.28-7.22 (m, 3 H), 3.75 (s, 3 H), 2.34 (s, 3 H). ^¹³C NMR (62.5 MHz, CDCl₃): δ = 157.5, 139.5, 136.2, 130.9, 128.9, 127.5, 126.6, 53.8, 17.6. HRMS: m/z calcd for [M + Na]⁺ C₉H₁₁NO₃Na: 204.0631; found: 204.0634.
Methyl N-3-Tolyl-N-hydroxy Carbamate
^¹H NMR (400 MHz, CDCl₃): δ = 8.2 (br s, 1 H), 7.33-7.28 (m, 3 H), 7.06 (d, 2 H, J = 6.6 Hz), 3.84 (s, 3 H), 2.40 (s, 3 H). ^¹³C NMR (62.5 MHz, CDCl₃): δ = 156.4, 140.9, 138.5, 128.4, 126.9, 123.1, 119.7, 53.7, 21.5. HRMS: m/z calcd for [M]⁺ C₉H₁₁NO₃: 181.0739; found: 181.0735.
Methyl N-4-Tolyl-N-hydroxy Carbamate
^¹H NMR (400 MHz, CDCl₃): δ = 2.34 (s, 3 H), 3.77 (s, 3 H), 7.15 (d, 2 H, J = 8.2 Hz), 7.33 (d, 2 H, J = 8.2 Hz), 8.55 (br s, 1 H). ^¹³C NMR (62.5 MHz, CDCl₃): δ = 156.4, 138.4, 136.2, 129.2, 122.8, 53.7, 21.0. HRMS: m/z calcd for [M + Na]⁺ C₉H₁₁NO₃Na: 204.0631; found: 204.0629.
Methyl N-3-Trifluoromethylphenyl-N-hydroxy Carbamate
^¹H NMR (400 MHz, CDCl₃): δ = 7.80 (s, 1 H), 7.71 (d, 1 H, J = 8.0 Hz), 7.49-7.41 (m, 2 H), 7.20 (br s, 1 H), 3.89 (s, 3 H). ^¹³C NMR (62.5 MHz, CDCl₃): δ = 155.7, 141.3, 131.1 (q, CF₃, J = 32 Hz), 129.1, 129.1, 124.1, 122.0, 117.9, 54.0. HRMS: m/z calcd for [M]⁺ C₉H₈F₃NO₃: 235.0456; found: 235.0453.
Methyl N-4-Iodophenyl-N-hydroxy Carbamate
^¹H NMR (400 MHz, MeOD): δ = 7.65 (d, 2 H, J = 7.0 Hz), 7.25 (d, 2 H, J = 7.0 Hz), 3.83 (s, 3 H). ^¹³C NMR (62.5 MHz, MeOD): δ = 156.9, 143.5, 138.6, 123.6, 89.0, 53.8. HRMS: m/z calcd for [M + H]⁺ C₈H₈INO₃: 292.9549; found: 292.9550.
Methyl N-4-Cyanophenyl-N-hydroxy Carbamate
^¹H NMR (400 MHz, CDCl₃): δ = 7.69 (d, 2 H, J = 7.0 Hz), 7.60 (d, 2 H, J = 7.0 Hz), 3.90 (s, 3 H). ^¹³C NMR (62.5 MHz, CDCl₃): δ = 154.6, 144.3, 132.8, 119.3, 118.7, 107.3, 54.3. HRMS: m/z calcd for [M + Na]⁺ C₉H₈N₂O₃Na: 215.0427; found: 215.0427.